Phreesia (NYSE:PHR) Stock Price Up 3.7%

Phreesia, Inc. (NYSE:PHR) rose 3.7% during mid-day trading on Wednesday . The stock traded as high as $24.86 and last traded at $24.68. Approximately 81,725 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 459,293 shares. The stock had previously closed at $23.80.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on PHR shares. DA Davidson reissued a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Thursday. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Thursday. Robert W. Baird raised their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Stephens reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Phreesia in a research note on Friday, May 31st. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $30.77.

Phreesia Trading Up 6.3 %

The firm has a market cap of $1.47 billion, a P/E ratio of -11.84 and a beta of 0.93. The firm has a fifty day simple moving average of $23.33 and a 200-day simple moving average of $22.82. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.76 and a quick ratio of 1.76.

Insider Activity at Phreesia

In other news, Director Mark Douglas Smith sold 7,000 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $25.00, for a total transaction of $175,000.00. Following the completion of the sale, the director now directly owns 30,653 shares of the company’s stock, valued at $766,325. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Phreesia news, CEO Chaim Indig sold 2,644 shares of Phreesia stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $62,768.56. Following the transaction, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at approximately $28,947,630.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $25.00, for a total transaction of $175,000.00. Following the completion of the sale, the director now owns 30,653 shares of the company’s stock, valued at approximately $766,325. The disclosure for this sale can be found here. In the last 90 days, insiders sold 29,337 shares of company stock valued at $736,750. 5.80% of the stock is owned by company insiders.

Institutional Investors Weigh In On Phreesia

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after purchasing an additional 194,035 shares during the period. Brown Advisory Inc. boosted its holdings in shares of Phreesia by 22.2% in the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after buying an additional 716,374 shares during the last quarter. Capital International Investors grew its position in Phreesia by 221.1% during the first quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock valued at $62,052,000 after buying an additional 1,785,463 shares during the period. Franklin Resources Inc. increased its holdings in Phreesia by 15.0% during the fourth quarter. Franklin Resources Inc. now owns 1,484,663 shares of the company’s stock worth $34,370,000 after buying an additional 193,480 shares during the last quarter. Finally, Champlain Investment Partners LLC bought a new stake in Phreesia in the first quarter worth about $29,941,000. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.